Cymabay Therapeutics
AcquiredNewark, United States · Founded 2000 · $320.7M raised
- Headquarters
- Newark, California
- Employees
- 11–50
- Founded
- 2000
- Business Model
- B2B
- Website
- cymabay.com
- Total Funding
- $320.7M
- Last Round
- $85.0M Venture RoundJan 2023
- Rounds
- 4
About
Clinical-stage biopharmaceutical company developing therapies for liver and other chronic diseases, acquired by Gilead Sciences in 2024.
Summary
Cymabay Therapeutics is a Biotech company based in Newark, United States, founded in 2000. It has raised $320.7M in total across 4 rounds, most recently a $85.0M Venture Round round in Jan 2023. Investors include Gilead Sciences and Omega Funds.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2024
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...